Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02064712 · ClinicalTrials.gov registry record · NA

Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates

A NA study of Infant, Premature and Infant, Newborn, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
226
Enrollment target
1
Study location

NCT02064712: Completed NA study of Infant, Premature and Infant, Newborn, sponsored by University of Texas Southwestern Medical Center.

NCT02064712 is a NA study of Infant, Premature and Infant, Newborn that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 226 participants, below the 9,873-participant average among 16 other Infant, Premature trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02064712, a NA study of Infant, Premature and Infant, Newborn, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
226 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine an optimal strategy to wean nasal continuous positive airway pressure (NCPAP) in preterm babies. The investigators hypothesize that babies that are taken off NCPAP at lower settings will need fewer total days on NCPAP than those babies taken off at higher settings.

Primary Outcome

Total number of days of CPAP therapy during the hospital stay

Interventions

  • OTHER Low CPAP Wean
  • OTHER High CPAP Wean

Study Locations (1)

Texas

  • Parkland Memorial Hospital - Dallas

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2014-09
Est. Completion 2018-10
Phase NA

What the finished NCT02064712 record still lists

NCT02064712 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 9,873-participant average among 16 other Infant, Premature trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Infant, Premature appearing as the primary indexed condition, and to 2 interventions - of which Low CPAP Wean is the first listed.

NCT02064712 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02064712 about?

NCT02064712 is a clinical study titled "Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates". The purpose of this study is to determine an optimal strategy to wean nasal continuous positive airway pressure (NCPAP) in preterm babies. The investigators hypothesize that babies that are taken off NCPAP at lower settings will need fewer total days on NCPAP than those babies taken off at higher se...

What is the current status of trial NCT02064712?

This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2014-09. Estimated completion is 2018-10.

What conditions does trial NCT02064712 study?

This clinical trial studies the following conditions: Infant, Premature, Infant, Newborn.

What interventions are being tested in trial NCT02064712?

The interventions under investigation include: Low CPAP Wean (OTHER), High CPAP Wean (OTHER).

Who is sponsoring clinical trial NCT02064712?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02064712 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant, Premature

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02064712's enrollment target sits among peer trials

226 11th of 16 higher than 6 of 16 other Infant, Premature trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infant, Premature trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04419272 · 226 participants · Phase 4

    Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  • NCT05449002 · 226 participants · NA

    Digital Single Session Intervention for Youth Mental Health

  • NCT05488054 · 226 participants · NA

    Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

  • NCT05924477 · 226 participants · NA

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02064712, the US trial registry maintained by the National Library of Medicine. NCT02064712 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.